Amwill Healthcare Reports Precise IPO Fund Utilization for H1 2025
Amwill Health Care disclosed its IPO fund utilization report for the half-year ended September 30, 2025. The company has utilized ₹3,288.08 lakhs out of the total ₹4,888.00 lakhs raised, adhering strictly to the allocations stated in its prospectus. Unutilized funds of ₹1,546.61 lakhs are invested in bank term deposits. The Audit Committee confirmed no deviations from the stated objectives. The company's transparency aligns with SEBI regulations, potentially boosting investor confidence.
*this image is generated using AI for illustrative purposes only.
Amwill Health Care has disclosed its Initial Public Offering (IPO) fund utilization report for the half-year ended September 30, 2025, demonstrating strict adherence to its stated objectives. The company, which raised funds through equity shares, has provided a detailed breakdown of its expenditure in line with the original allocations.
IPO Fund Allocation and Utilization
The company's fund utilization as of September 30, 2025, is summarized in the following table:
| Purpose | Original Allocation (₹ in lakhs) | Utilized Amount (₹ in lakhs) |
|---|---|---|
| Working Capital Requirements | 2,500.00 | 1,227.63 |
| Marketing and Brand Building Activities | 500.00 | 240.77 |
| General Corporate Purposes | 1,218.34 | 1,150.02 |
| Issue Expenses | 669.66 | 669.66 |
| Total | 4,888.00 | 3,288.08 |
Unutilized Funds
The company reported that the unutilized IPO proceeds, amounting to ₹1,546.61 lakhs, have been invested in term deposits with a bank. An additional ₹53.30 lakhs are maintained in a current account for intended purposes.
Audit Committee Review
The Audit Committee of Amwill Healthcare Limited reviewed the fund utilization statement at its meeting held on November 04, 2025. The committee confirmed that there has been no deviation or variation in the utilization of IPO proceeds from the objectives stated in the company's prospectus dated February 10, 2025.
Management Statement
Anshu Anshuman, Company Secretary and Compliance Officer of Amwill Healthcare Limited, stated, "We hereby confirm that during the half-year ended September 30, 2025, of the financial year 2025-26, there is no deviation or variation in the utilization of proceeds of the IPO from the objects stated in the Prospectus."
Transparency and Compliance
The company's disclosure aligns with Regulation 32 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, and SEBI Circular No. CIR/CFD/CMD1/162/2019 dated December 24, 2019. This level of transparency provides investors with a clear view of how the IPO funds are being utilized and ensures compliance with regulatory requirements.
Amwill Healthcare's meticulous reporting and adherence to its stated objectives demonstrate a commitment to transparency and responsible fund management, which may bolster investor confidence in the company's financial practices.
Historical Stock Returns for Amwill Health Care
| 1 Day | 5 Days | 1 Month | 6 Months | 1 Year | 5 Years |
|---|---|---|---|---|---|
| -3.89% | +5.08% | +14.63% | -32.38% | -49.91% | -49.91% |
17
